Supplementary appendix: Oral polio vaccination and hospital admissions with non-polio infections in Denmark: Nationwide retrospective cohort study
|
|
- Brenda Bruce
- 6 years ago
- Views:
Transcription
1 Supplementary appendix: Oral polio vaccination and hospital admissions with non-polio infections in Denmark: Nationwide retrospective cohort study Signe Sørup, Lone G. Stensballe, Tyra G. Krause, Peter Aaby, Christine S. Benn, and Henrik Ravn Supplementary Methods. Additional doses of OPV Figure S1. Incidence rate and incidence rate ratio according to most recent vaccine and sequence for admissions with subtypes of infections Table S1. Number of admissions and adjusted incidence rate ratio for infectious-disease hospital admissions by type of infection and duration of admission according to the most recent vaccine. Table S2. Incidence rate and incidence rate ratio of hospital admissions with upper respiratory infections, subdivided by diagnosis of otitis media or not, according to the most recent vaccine Results S1: Additional doses of OPV Table S3. Determinants of additional doses of OPV Table S4. Incidence rate and incidence rate ratio for additional doses pf OPV Table S5. Incidence and incidence rate ratio of emergency department visits following unintentional injury according to the most recent vaccine Table S6. Results for interaction between most recent vaccine and sex for admissions due any type of infection Results S2: Sensitivity analyses 1
2 Supplementary Methods: Additional doses of OPV The study included all children from the main study cohort who had received and who had not received other types of vaccines than OPV following (last date of follow-up, December 31, 2004). We performed the analyses with the following outcomes: admissions with any type of infection, admissions with the 4 subtypes of infections, and emergency department visits following unintentional injury. The analyses was performed both with the second and third dose of OPV (OPV2 and OPV3) as separate groups and as one joint group. For the outcomes of admissions with any type of infection and emergency department visits following unintentional injury, children who had as their most recent vaccine at 36 months of age and who had not received any doses of OPV yet were also included. However, only a limited number of children had DTaP-IPV-Hib3 or + as the most recent vaccine at 36 months of age and these children were not included due to limited power. 2
3 Figure S1. Incidence rate and Incidence rate ratio according to most recent vaccine and sequence for admissions with upper respiratory infections (a), lower respiratory infections (b), gastrointestinal infections (c), and other types of infections (d). a) Admission with upper respiratory infection Adj. IRR b =0.90 ( ) Rate a 2.1 (763/37,065) Adj. IRR b =1.04 ( ) Rate a 1.8 (1512/83,263) DTaP-IPV-Hib3 Rate a 2.8 (172/6243) Adj. IRR b =0.94 ( ) Rate a 2.0 (132/6656) Adj. IRR b =1.49 ( ) Rate a 2.9 (22/770) Adj. IRR b =0.71 ( ) + Rate a 1.5 (28/1927) b) Admission with lower respiratory infection Rate a 1.6 (607/37,065) Adj. IRR b =0.95 ( ) Rate a 1.3 (1056/83,263) Adj. IRR b =0.76 ( ) DTaP-IPV-Hib3 Rate a 2.7 (170/6243) Adj. IRR b =0.77 ( ) Rate a 1.5 (101/6656) Adj. IRR b =1.11 ( ) Rate a 1.4 (11/770) Adj. IRR b =0.79 ( ) + Rate a 1.5 (29/1927) 3
4 c) Admission with gastrointestinal infection Adj. IRR b =1.00 Rate a 0.7 ( ) (247/37,065) Rate a 0.7 (598/83,263) Adj. IRR b =0.88 ( ) DTaP-IPV-Hib3 Rate a 0.9 (58/6243) Adj. IRR b =0.91 ( ) Rate a 0.8 (52/6656) Adj. IRR b =0.18 ( ) Rate a 0.1 (1/770) Adj. IRR b =0.86 ( ) + Rate a 0.7 (14/1927) d) Admission with other infections Rate a 1.2 (432/37,065) Adj. IRR b =0.94 ( ) Rate a 0.9 (750/83,263) Adj. IRR b =0.98 ( ) DTaP-IPV-Hib3 Rate a 1.4 (86/6243) Adj. IRR b =1.09 ( ) Rate a 1.2 (78/6656) Adj. IRR b =0.48 ( ) Rate a 0.5 (4/770) Adj. IRR b =0.69 ( ) + Rate a 0.8 (15/1927) Abbreviations: DTaP-IPV-Hib, inactivated vaccine against diphtheria, tetanus, pertussis (acellular), polio, and Haemophilus influenzae type b;, live vaccine against measles, mumps, and rubella; OPV, live oral polio vaccine; Adj, adjusted; IRR, incidence rate ratio. a The incidence rate per 100 person years and in brackets the number of admissions and number of person years. b IRRs for the vaccine type the arrow points at relative to the previous vaccine type in the sequence and in brackets 95% CI. Estimated from Cox proportional hazards model with age as underlying time, stratified by date of birth and adjusted for mother smoking during pregnancy, sex, birth weight, gestational age, caesarean section, chronic diseases, number of infectious disease admissions before 24 months of age, admitted to hospital for any cause within the last 30 days, maternal age at birth of the child, highest educational level for the female adult in the household, parental place of birth, adults in the household, income quintiles for the household, other children in the household, and population density. c P value from a Wald test of the equality of rates for as most recent vaccine in the adjusted model. d P value from a Wald test of the equality of rates for as most recent vaccine in the adjusted model. 4
5 Table S1. Number of admissions and adjusted incidence rate ratio for infectious-disease hospital admissions by type of infection and duration of admission according to the most recent vaccine. Duration All durations 0-1 days >=2days Upper respiratory infections Number of admissions (%) a 2629 (100%) 1852 (70.4%) 777 (29.6%) Adjusted IRR b DTaP-IPV-Hib3 1 (ref) 1 (ref) 1 (ref) 0.91 ( ) 0.99 ( ) 0.78 ( ) 0.93 ( ) 1.03 ( ) 0.77 ( ) ( ) 0.71 ( ) 0.69 ( ) Lower respiratory infections Number of admissions (%) a 1974 (100%) 982(49.7%) 992 (50.3%) Adjusted IRR b DTaP-IPV-Hib3 1 (ref) 1 (ref) 1 (ref) 0.77 ( ) 0.81 ( ) 0.73 ( ) 0.73 ( ) 0.73 ( ) 0.73 ( ) ( ) 0.92 ( ) 0.65 ( ) Gastrointestinal infections Number of admissions (%) a 970 (100%) 537 (55.4%) 433 (44.6%) Adjusted IRR b DTaP-IPV-Hib3 1 (ref) 1 (ref) 1 (ref) 0.86 ( ) 1.05 ( ) 0.70 ( ) 0.89 ( ) 1.05 ( ) 0.76 ( ) ( ) 0.94 ( ) 0.84 ( ) Other infections Number of admissions (%) a 1365 (100%) 696 (51.0%) 669 (49.0%) Adjusted IRR b DTaP-IPV-Hib3 1 (ref) 1 (ref) 1 (ref) 0.97 ( ) 1.06 ( ) 0.86 ( ) 0.94 ( ) 0.95 ( ) 0.93 ( ) ( ) 0.48 ( ) 0.87 ( ) Abbreviations: IRR, incidence rate ratio; CI, confidence interval; DTaP-IPV-Hib, inactivated vaccine against diphtheria, tetanus, pertussis (acellular), polio, and Haemophilus influenzae type b;, live vaccine against measles, mumps, and rubella; OPV, live oral polio vaccine. a The total number of admissions by the four types of admissions add to more than the total number of admissions, as admissions may have more than one ICD-10 diagnosis code, and ICD10 codes from more than one type of infection were included in both groups. b Cox proportional hazards model with age as underlying time, stratified by date of birth and adjusted for mother smoking during pregnancy, sex, birth weight, gestational age, caesarean section, chronic diseases, number of infectious disease admissions before 24 months of age, admitted to hospital for any cause within the last 30 days, maternal age at birth of the child, highest educational level for the female adult in the household, parental place of birth, adults in the household, income quintiles for the household, other children in the household, and population density. 5
6 Table S2. Incidence rate and incidence rate ratio of hospital admissions with upper respiratory infections, subdivided by diagnosis of otitis media or not, according to the most recent vaccine. Admissions per 100 person-years (Admissions/ Personyears) Unadjusted IRR a Adjusted IRR b a) All upper respiratory infections c DTaP-IPV-Hib3 2.7 (179/6587) 1 (ref) 1 (ref) 2.1 (802/39,057) 0.76 ( ) 0.90 ( ) 1.8 (1681/91,786) 0.73 ( ) 0.93 ( ) (29/1979) 0.61 ( ) 0.71 ( ) b) Otitis media (ICD-10 codes DH65.0-DH66.9) c DTaP-IPV-Hib3 1.0 (66/6587) 1 (ref) 1 (ref) 0.6 (229/39,057) 0.57 ( ) 0.71 ( ) 0.5 (456/91,786) 0.58 ( ) 0.81 ( ) (7/1979) 0.44 ( ) 0.53 ( ) c) Other types of upper respiratory infections c DTaP-IPV-Hib3 1.7 (113/6587) 1 (ref) 1 (ref) 1.5 (573/39,057) 0.88 ( ) 1.01 ( ) 1.3 (1225/91,786) 0.82 ( ) 1.00 ( ) (22/1979) 0.70 ( ) 0.81 ( ) Abbreviations: IRR, incidence rate ratio; CI, confidence interval; DTaP-IPV-Hib, inactivated vaccine against diphtheria, tetanus, pertussis (acellular), polio, and Haemophilus influenzae type b;, live vaccine against measles, mumps, and rubella; OPV, live oral polio vaccine. a Cox proportional hazards model with age as underlying time and stratified by date of birth thereby controlling for age and season. b Cox proportional hazards model with age as underlying time, stratified by date of birth and adjusted for maternal smoking during pregnancy, sex, birth weight, gestational age, caesarean section, chronic diseases, number of infectious disease admissions before 24 months of age, admitted to hospital for any cause within the last 30 days, maternal age at birth of the child, parental place of birth, adults in the household, other children in the household, and population density. c Information on specific ICD-10 diagnosis codes where only available in data without linkage to highest educational level for the female adult in the household and income quintiles for the household. Therefore these analyses include 141,081 children and in total 2691 admissions with upper respiratory infections, as children with missing information on highest educational level for the female adult in the household and income quintiles for the household are included in these analyses. 6
7 Results S1: Additional doses of OPV The analyses included 105,936 children from the main study cohort who had received and who had not received other types of vaccines than OPV following ; the analyses of admissions with any type of infection and emergency department visits following unintentional injury also include 24,498 additional children who had as their most recent vaccine at 36 months of age (giving a total of 130,434 children). The distribution of the most recent vaccine according to background factors at 42 and 54 months of age is given in etable3. The results for the analyses of the association between the most recent vaccine and the different outcomes are displayed in Table S4. 7
8 Table S3. Distribution of most recent vaccine at 42 and 54 months of age according to background factors. % (N) Maternal smoking during pregnancy 42 months of age 54 months of age OPV3 OPV2 % (N) P Value a % (N) % (N) OPV2 % (N) 8 OPV3 % (N) P Value a No 16.6% (13,530) 82.8% (67,715) 0.6% (497) < % (6476) 21.3% (17,294) 70.7% (57,356) <0.001 Yes 20.3% (4436) 79.1% (17,326) 0.6% (129) 10.4% (2275) 24.6% (5362) 65.0% (14,190) Sex Male 17.5% (9233) 82.0% (43,366) 0.6% (297) % (4412) 22.2% (11,654) 69.4% (36,473) Female 17.2% (8733) 82.1% (41,675) 0.6% (329) 8.6% (4339) 21.8% (11,002) 69.6% (35,073) Birth weight, gram <= % (286) 81.4% (1302) 0.7% (11) % (149) 22.7% (363) 68.0% (1090) % (551) 81.7% (2564) 0.7% (22) 8.6% (267) 22.3% (695) 69.2% (2160) % (2168) 82.0% (10,283) 0.8% (95) 8.5% (1063) 21.6% (2684) 69.9% (8686) % (5731) 82.0% (26,991) 0.6% (202) 8.7% (2842) 22.1% (7235) 69.2% (22,671) % (6074) 82.1% (28,775) 0.6% (202) 8.4% (2937) 22.1% (7681) 69.5% (24,171) % (2542) 82.3% (12,194) 0.5% (77) 8.0% (1182) 22.2% (3265) 69.8% (10,260) > % (614) 82.3% (2932) 0.5% (17) 8.8% (311) 20.6% (733) 70.6% (2508) Gestational age, weeks < % (911) 82.3% (4439) 0.8% (43) % (477) 20.5% (1106) 70.6% (3804) >= % (17,055) 82.0% (80,602) 0.6% (583) 8.5% (8274) 22.1% (21,550) 69.4 (67,742) Caesarean section No 17.4% (15,543) 82.0% (73,426) 0.6% (548) % (7562) 22.1% (19,696) 69.4% (61,691) Yes 17.2% (2423) 82.3% (11,615) 0.6% (78) 8.5% (1189) 21.1% (2960) 70.4% (9855) Chronic diseases No 17.3% (17,322) 82.1% (82,398) 0.6% (608) % (8386) 22.0% (21,883) 69.6% (69,258) <0.001 Yes 19.5% (644) 80.0% (2643) 0.5% (18) 10.7% (365) 22.6% (773) 66.8% (2288) Number of admissions due to infections before 24 months of age None 17.0% (14,383) 82.4% (69,476) 0.6% (501) < % (6956) 21.7% (18,211) 70.0% (58,646) <0.001 One 18.0% (2687) 81.4% (12,183) 0.6% (93) 8.8% (1313) 22.9% (3403) 68.3% (10,143) Two 20.5% (615) 78.9% (2370) 0.6% (18) 10.6% (316) 24.2% (720) 65.2% (1942)
9 Three or more 21.5% (281) 77.4% (1012) 1.1% (14) 12.7% (166) 24.7% (322) 62.5% (815) Admitted to hospital for any cause within the last month No 17.3% (17,813) 82.1 (84,555) 0.6 (625) < % (8686) 22.0% (22,530) 69.5% (71,191) Yes 23.9% (153) 75.9% (486) 0.2% (1) 11.9% (65) 23.1% (126) 65.0% (355) Maternal age at birth of the child, years <= % (390) 73.6% (1139) 1.2% (19) < % (230) 29.1% (447) 56.0% (860) < % (2780) 80.1% (11,630) 0.7% (101) 10.0% (1449) 24.1% (3479) 65.8% (9493) % (6373) 83.0% (32,249) 0.6% (228) 7.7% (2985) 21.4% (8242) 70.9% (27,360) % (6036) 82.5% (29,354) 0.6% (197) 8.0% (2841) 21.5% (7601) 70.5% (24,907) % (2081) 81.4% (9429) 0.6% (67) 9.3 % (1074) 22.0% (2528) 68.7% (7914) >= % (306) 79.5% (1240) 0.9% (14) 11.1% (172) 23.3% (359) 65.6% (1012) Highest educational level for the female adult in the household Primary school 21.1% (4621) 78.3% (17,180) 0.7% (143) < % (2462) 25.3% (5512) 63.5% (13,852) <0.001 High school examination 18.0% (1801) 81.4% (8165) 0.6% (65) 8.7% (867) 22.5% (2236) 68.8% (6840) Vocational training 15.8% (6363) 83.6% (33,600) 0.6% (231) 7.6% (3044) 20.6% (8252) 71.7% (28,683) Bachelor or academy profession 16.2% (4037) 83.2% (20,728) 0.6% (149) 7.4% (1840) 21.0% (5200) 71.5% (17,670) Master s degree or higher 17.5% (1144) 82.0% (5368) 0.6% (38) 8.3% (538) 22.4% (1456) 69.3% (4501) Parental place of birth Denmark 16.7% (14,702) 82.8% (72,993) 0.6% (497) < % (7075) 21.2% (18,631) 70.7% (62,046) <0.001 Denmark and foreign 20.5% (1630) 78.9% (6274) 0.6% (46) 10.4% (821) 25.2% (1983) 64.4% (5064) Foreign 21.8% (1634) 77.1% (5774) 1.1% (83) 11.7% (855) 27.8% (2042) 60.5% (4436) Adults in the household Two adults 16.9% (16,424) 82.5% (80,199) 0.6% (577) < % (7874) 21.7% (20,975) 70.1 (67,676) <0.001 Single parent 24.0% (1542) 75.3% (4842) 0.8% (49) 13.6% (877) 26.2% (1681) 60.2% (3870) Income quintiles for the household 1 st (lowest) 22.6% (3633) 76.6% (12,315) 0.8% (133) < % (2019) 26.6% (4247) 60.8% (9699) < nd 18.7% (3646) 80.7% (15,717) 0.6% (117) 9.4% (1828) 23.6% (4579) 66.9% (12,960) 3 rd 16.6% (3552) 82.8% (17,693) 0.5% (112) 7.7% (1643) 21.5% (4558) 70.8% (15,012) 4 th 15.3% (3526) 84.1% (19,415) 0.6% (138) 7.1% (1622) 20.0% (4584) 73.0% (16,750) 9
10 5 th (highest) 15.3% (3609) 84.2% (19,901) 0.5% (126) 7.0% (1639) 20.0% (4688) 73.0% (17,125) Other children in the household No 15.7% (6889) 83.7% (36,607) 0.6% (257) < % (3209) 20.6% (8922) 72.0% (31,218) <0.001 Yes 18.5% (11,077) 80.9% (48,434) 0.6% (369) 9.3% (5542) 23.0% (13,734) 67.7% (40,328) Population density, inhabitants per km 2 < % (1175) 83.9% (6297) 0.4% (29) < % (537) 20.2% (1516) 72.6% (5437) < % (10,387) 82.8% (51,755) 0.6% (390) 8.0% (4977) 21.4% (13,307) 70.6% (43,822) % (3321) 82.1% (15,696) 0.5% (98) 8.8% (1663) 21.9% (4154) 69.3% (13,158) % (909) 79.4% (3617) 0.6% (27) 9.8% (444) 24.5% (1111) 65.7% (2976) >= % (2174) 77.3% (7676) 0.8% (82) 11.5% (1130) 26.1% (2568) 62.5% (6153) Abbreviations: OPV, live oral polio vaccine Note: At 42 months of age 103,633 children was included and at 54 months of age 102,953 children was included. a P values from bivariate Χ 2 test. 10
11 Table S4. Incidence rate and incidence rate ratio for hospital admissions with any type of infection (a), hospital admissions with upper respiratory infections (b), hospital admissions with lower respiratory infections (c), hospital admissions with gastrointestinal infections (d), hospital admissions with other infections (e), and emergency department visits following unintentional injury (f) according to the most recent vaccine for children aged 36 to 60 months. Events per 100 personyears (Events/ Person-years) Unadjusted IRR* Adjusted IRR a) Admissions with any type of infection 3.0 (1506/49,715) 1.00 ( ) 0.99 ( ) 3.4 (1124/33,130) 1 (ref) 1 (ref) OPV2 2.9 (3029/106,249) 0.84 ( ) 0.93 ( ) OPV3 2.2 (1430/66,419) 0.73 ( ) 0.87 ( ) OPV2 or OPV3 2.6 (4459/172,668) 0.82 ( ) 0.92 ( ) b) Admissions with upper respiratory infections 1.5 (504/33,130) 1 (ref) 1 (ref) OPV2 1.2 (1325/106,249) 0.81 ( ) 0.87 ( ) OPV3 1.0 (693/66,419) 0.75 ( ) 0.87 ( ) OPV2 or OPV3 1.2 (2018/172,668) 0.80 ( ) 0.87 ( ) c) Admissions with lower respiratory infections 0.7 (246/33,130) 1 (ref) 1 (ref) OPV2 0.6 (662/106,249) 0.83 ( ) 0.95 ( ) OPV3 0.4 (246/66,419) 0.67 ( ) 0.84 ( ) OPV2 or OPV3 0.5 (908/172,668) 0.80 ( ) 0.93 ( ) d) Admissions with gastrointestinal infections 0.4 (138/33,130) 1 (ref) 1 (ref) OPV2 0.4 (387/106,249) 0.93 ( ) 0.99 ( ) OPV3 0.2 (161/66,419) 0.76 ( ) 0.84 ( ) OPV2 or OPV3 0.3 (548/172,668) 0.90 ( ) 0.97 ( ) e) Admissions with other infections 0.9 (294/33,130) 1 (ref) 1 (ref) OPV2 0.7 (784/106,249) 0.80 ( ) 0.92 ( ) OPV3 0.6 (395/66,419) 0.69 ( ) 0.86 ( ) OPV2 or OPV3 0.7 (1179/172,668) 0.78 ( ) 0.91 ( ) f) Emergency department visits following unintentional injury 13.6 (6727/49,535) 1.03 ( ) 1.02 ( ) 14.5 (4778/33,005) 1 (ref) 1 (ref) OPV (14,680/105,839) 0.95 ( ) 0.98 ( ) OPV (8074/66,183) 0.94 ( ) 1.00 ( ) OPV2 or OPV (22,754/172,022) 0.95 ( ) 0.98 ( ) Abbreviations: IRR, incidence rate ratio; CI, confidence interval; DTaP-IPV-Hib, inactivated vaccine against diphtheria, tetanus, pertussis (acellular), polio, and Haemophilus influenzae type b;, live vaccine against measles, mumps, and rubella; OPV, live oral polio vaccine (the number indicate the dose number). *Cox proportional hazards model with age as underlying time and stratified by date of birth thereby controlling for age and season. Cox proportional hazards model with age as underlying time, stratified by date of birth and adjusted for mother smoking during pregnancy, sex, birth weight, gestational age, caesarean section, chronic diseases, number of infectious disease admissions before 36 months of age, admitted to hospital for any cause within the last 30 days, maternal age at birth of the child, highest educational level for the female adult in the household, parental place of 11
12 birth, adults in the household, income quintiles for the household, other children in the household, and population density. This is the joint group of OPV2 and OPV3. 12
13 Table S5. Incidence and incidence rate ratio of emergency department visits following unintentional injury according to the most recent vaccine. Emergency visits per 100 person-years (Emergency visits / Person-years) Unadjusted IRR a Adjusted IRR b Most recent vaccine DTaP-IPV-Hib (972/6228) 1 (ref) 1 (ref) 14.8 (5565/37,721) 0.95 ( ) 0.97 ( ) 14.1 (12,640/89,627) 0.90 ( ) 0.96 ( ) (296/1920) 0.99 ( ) 1.02 ( ) Abbreviations: IRR, incidence rate ratio; CI, confidence interval; DTaP-IPV-Hib, inactivated vaccine against diphtheria, tetanus, pertussis (acellular), polio, and Haemophilus influenzae type b;, live vaccine against measles, mumps, and rubella; OPV, live oral polio vaccine. a Cox proportional hazards model with age as underlying time and stratified by date of birth thereby controlling for age and season. b Cox proportional hazards model with age as underlying time, stratified by date of birth and adjusted for mother smoking during pregnancy, sex, birth weight, gestational age, caesarean section, chronic diseases, number of infectious disease admissions before 24 months of age, admitted to hospital for any cause within the last 30 days, maternal age at birth of the child, highest educational level for the female adult in the household, parental place of birth, adults in the household, income quintiles for the household, other children in the household, and population density. 13
14 Table S6. Results for interaction between most recent vaccine and sex for admissions due any type of infection Admissions per 100 person-years (Admissions/ Person-years) Unadjusted IRR a Adjusted IRR b Characteristics Female DTaP-IPV-Hib3 5.8 (178/3043) 1 (ref) 1 (ref) 4.2 (777/18,511) 0.72 ( ) 0.86 ( ) 3.6 (1601/44,062) 0.65 ( ) 0.83 ( ) (29/893) 0.60 ( ) 0.72 ( ) Male DTaP-IPV-Hib3 8.6 (274/3200) 1 (ref) 1 (ref) 6.0 (1161/19,325) 0.72 ( ) 0.85 ( ) 5.3 (2439/45,857) 0.66 ( ) 0.86 ( ) (54/1034) 0.66 ( ) 0.78 ( ) P equality for P equality for P equality for Abbreviations: IRR, incidence rate ratio; CI, confidence interval; DTaP-IPV-Hib, inactivated vaccine against diphtheria, tetanus, pertussis (acellular), polio, and Haemophilus influenzae type b;, live vaccine against measles, mumps, and rubella. a Cox proportional hazards model with age as underlying time scale and stratified by date of birth thereby controlling for age and season. b Cox proportional hazards model with age as underlying time, stratified by date of birth and adjusted for mother smoking during pregnancy, sex, birth weight, gestational age, caesarean section, chronic diseases, number of infectious disease admissions before 24 months of age, admitted to hospital for any cause within the last 30 days, maternal age at birth of the child, highest educational level for the female adult in the household, parental place of birth, adults in the household, income quintiles for the household, other children in the household, and population density. 14
15 Results S2: Sensitivity analyses During follow-up 7 admissions with vaccine-targeted infections were registered (3 with pertussis, 1 with measles, 2 with mumps, and 1 with Haemophilus influenzae); exclusion of these admissions did not change the result (adjusted IRR for vs. DTaP-IPV-Hib3, 0.86; 95% CI, ). The results were also similar when admissions and person-years in the week of vaccination were excluded (adjusted IRR for vs. DTaP-IPV-Hib3, 0.84; 95% CI, ). The analysis that only included the 112,148 (81.6%) children who had all vaccines registered with their own personal registration number showed similar results (adjusted IRR for vs. DTaP-IPV-Hib3, 0.88; 95% CI, ). 15
Oral polio vaccination and hospital admissions with non-polio infections in
Oral polio vaccination and hospital admissions with non-polio infections in Denmark: Nationwide retrospective cohort study Signe Sørup 1 Lone G. Stensballe 1, 4 Tyra G. Krause 5 Peter Aaby 1, 3 Christine
More informationSyddansk Universitet. Published in: Open Forum Infectious Diseases. DOI: /ofid/ofv204. Publication date: 2016
Syddansk Universitet Oral Polio Vaccination and Hospital Admissions With Non-Polio Infections in Denmark Nationwide Retrospective Cohort Study Sørup, Signe; Stensballe, Lone G; Krause, Tyra Grove; Aaby,
More informationHealthy People 2020 objectives were released in 2010, with a 10-year horizon to achieve the goals by 2020.
Appendix 1: Healthy People 2020 Immunization-related Objectives Healthy People provides science-based, 10-year national objectives for improving the health of all Americans. For three decades, Healthy
More informationAppendix An Assessment Tool to Determine the Validity of Vaccine Doses
Appendix 4.4 - An Assessment Tool to Determine the Validity of Vaccine Doses Note: Refer to the Canadian Immunization Guide and New Brunswick (NB) immunization program directives for recommendations for
More informationProof of residency in East Orange is mandatory (see Residency Requirements)
Pre-K Registration Requirements Child must be at least 3 or 4 years old by October 1st of the current school year Immunization (shot records) are mandatory Age appropriate vaccinations for children entering
More informationPublic Health Wales Vaccine Preventable Disease Programme
Public Health Wales Vaccine Preventable Disease Programme LHB practice level reports Cwm Taf LHB July June August Page of Contents. Purpose and Background.... LHB Summary.... Practice level data Merthyr
More informationPATH Quick Reference Guide: Coding for Pediatric Health HEDIS Measures
PATH Quick Reference Guide: Coding for Pediatric Health HEDIS Measures This guide is designed to be a quick reference tool to help with medical coding of select Healthcare Effectiveness Data and Information
More informationImmunizations are among the most cost effective and widely used public health interventions.
Focused Issue of This Month Recommended by the Korean Pediatric Society, 2008 Hoan Jong Lee, MD Department of Pediatrics, Seoul National University College of Medicine E mail : hoanlee@snu.ac.kr J Korean
More informationCALIFORNIA CODE OF REGULATIONS TITLE 17, DIVISION 1, CHAPTER 4
CALIFORNIA CODE OF REGULATIONS TITLE 17, DIVISION 1, CHAPTER 4 Article 1. Definitions 6000. Admission. Admission means a pupil's first entry in a given public or private elementary or secondary school,
More informationSyrian Programme Refugees Advice on assessment of immunisation status and recommendations for additional immunisation
Syrian Programme Refugees Advice on assessment of immunisation status and recommendations for additional immunisation Background Information Immunisation services in Syria Syria had good immunisation services,
More informationEarly Learning Centre Immunisation Policy Legislation ACT Public Health Regulations (2000)
Early Learning Centre Immunisation Policy Legislation ACT Public Health Regulations (2000) National Quality Standard / Education and Care Services National Regulations Standard 2.1 Each child s health
More informationEconomic aspects of viral hepatitis in Turkey. Levent AKIN VIRAL HEPATITIS PREVENTION BOARD MEETING ISTANBUL, TURKEY, NOVEMBER 12-13, 2009
Economic aspects of viral hepatitis in Turkey Levent AKIN VIRAL HEPATITIS PREVENTION BOARD MEETING ISTANBUL, TURKEY, NOVEMBER 12-13, 2009 Vaccines currently recommended for children in National Immunization
More informationThe National Immunisation Schedule Update and Current issues. Dr Brenda Corcoran National Immunisation Office.
The National Immunisation Schedule Update and Current issues Dr Brenda Corcoran National Immunisation Office : Dates vaccines introduced into the Irish immunisation schedule Vaccine 1937-1999 Date introduced
More informationImmunizations for Children and Teens with Suppressed Immune Systems
Immunizations for Children and Teens with Suppressed Immune Systems Your child is starting treatment that will suppress the immune system. This will affect how your child s body responds to routine immunizations
More informationOVERVIEW OF THE NATIONAL CHILDHOOD IMMUNISATION PROGRAMME IN SINGAPORE
OVERVIEW OF THE NATIONAL CHILDHOOD IMMUNISATION PROGRAMME IN SINGAPORE Dr Tiong Wei Wei, MD, MPH Senior Assistant Director Policy and Control Branch, Communicable Diseases Division Ministry of Health 9
More informationCommunicable Disease & Immunization
Communicable Disease & Immunization Ingham County Health Surveillance Book 2016 Communicable Disease & Immunization - 1 Communicable Disease & Immunization T he control of communicable disease and immunization,
More informationLine Diagnosis 2017 Codes 2018 Codes. 3 Tuberculosis A15- through A19- A15- through A19-, O98.01-
Table 6A Code Changes Table 6A: Selected Diagnoses and Services Rendered * Indicates change from 2017 1-2. Selected Infectious and Parasitic Diseases Symptomatic / Asymptomatic HIV B20, B97.35, O98.7-,
More informationRequirements for new trials to examine offtarget. vaccination. Workshop on: Off-target (heterologous/non-specific) effects of vaccination.
Requirements for new trials to examine offtarget effects of vaccination Workshop on: Off-target (heterologous/non-specific) effects of vaccination Les Pensieres Jun 8-10, 2015 PEM Fine London School of
More informationGENERAL IMMUNIZATION GUIDE FOR CHILDCARE PROVIDERS August 2018 **CHILD VACCINES** DIPHTHERIA, TETANUS, PERTUSSIS VACCINES
GENERAL IMMUNIZATION GUIDE FOR CHILDCARE PROVIDERS August 2018 **CHILD VACCINES** DIPHTHERIA, TETANUS, PERTUSSIS VACCINES DTaP: Diphtheria, Tetanus, acellular Pertussis Vaccine Infanrix Licensed in 1997
More informationThe Danish childhood vaccination program SUMMARY IN ENGLISH
The Danish childhood vaccination program SUMMARY IN ENGLISH 2018 Why do we vaccinate children in Denmark? Childhood immunization programs are some of the most effective preventive public health measures
More informationThe schedule for childhood vaccination is:(web link to NHS Childhood Immunisation Schedule for 2008
Immunisations and vaccinations Immunisation is an effective public health intervention for promoting good health and protecting individuals and populations against serious disease and infection through
More informationManitoba Annual Immunization Surveillance Report
Annual Immunization Surveillance Report January 1 to December 31, 2014 Epidemiology & Surveillance Public Branch Public and Primary Care Division, y Living and Seniors Released: January 2016 TABLE OF CONTENTS
More informationHull s Joint Strategic Needs Assessment: Analysis of Public Health Outcomes Framework Data Children and Young People
s Joint Strategic Needs Assessment: Analysis of Public Health Outcomes Framework Data Children and Young People A summary of the data for each of the Public Health Outcomes Framework (PHOF) indicators
More informationRE-REGISTRATION FORM
RE-REGISTRATION FORM (please print) Name of Child: Male / Female Home Phone #: street city/state/zip Date of Birth: E-mail address: Second e-mail: Mother s Social Security #: Employer s Father s Social
More informationImmunizations (Guideline Intervals Using The Rule of Six for Vaccines Birth to Six Years)
Immunizations (Guideline Intervals Using The Rule of Six for Vaccines Birth to Six Years) Guideline developed by Shelly Baldwin, MD, in collaboration with the ANGELS Team. Last reviewed by Shelly Baldwin,
More information1. Executive Summary 2. Worldwide Pediatric Vaccines Market and Forecast ( ) 3. Worldwide Pediatric Vaccines Market Share & Forecast (Sector
1. Executive Summary 2. Worldwide Pediatric Vaccines Market and Forecast (2006 ) 3. Worldwide Pediatric Vaccines Market Share & Forecast (Sector wise) (2005 ) 4. Worldwide Pediatric Vaccines Market Share
More informationWESTFIELD PUBLIC SCHOOLS 5320 IMMUNIZATION
WESTFIELD PUBLIC SCHOOLS PUPILS WESTFIELD, NEW JERSEY 5320 Regulations follow Page 1 of 1 5320 IMMUNIZATION In order to safeguard the school community from the spread of certain communicable diseases and
More information7.0 Nunavut Childhood and Adult Immunization Schedules and Catch-up Aids
7.0 Nunavut Childhood and Adult Immunization Schedules and Catch-up Aids Contents Introduction Nunavut Recommended Childhood Immunization Schedule Nunavut Routine Adult Immunization Schedule Nunavut Immunization
More informationPreventive care is important at every age. Making good health choices now can boost your health and well-being for a lifetime.
Adult Recommendations Preventive care is important at every age. Making good health choices now can boost your health and well-being for a lifetime. Asthma and COPD Well-Child Visits Children s Immunization
More informationManitoba Health, Healthy Living and Seniors
Manitoba Health, Healthy Living and Seniors Manitoba Annual Immunization Surveillance Report, 2012 and 2013 January 1, 2012 to December 31, 2013 with 5-year average comparison (January 1, 2007 to December
More informationSchool Nurse Regional Update School Year Immunizations COLORADO IMMUNIZATION BRANCH
School Nurse Regional Update 2017-18 School Year Immunizations COLORADO IMMUNIZATION BRANCH Talking Points Child Care Immunizations K through 12 th Grade Immunizations Official Medical and Non-Medical
More informationPediatric Quality Measure Information Sheet 2017
Prevention and Screening Adolescent Preventive Care Measures (APC) The percentage of adolescents 12-17 years of age who had at least one outpatient visit with a PCP or OB/ GYN practitioner during the measurement
More informationCurrent National Immunisation Schedule Dr Brenda Corcoran National Immunisation Office.
Current National Immunisation Schedule 2012 Dr Brenda Corcoran National Immunisation Office Objectives To outline immunisation schedules in Ireland Primary childhood schedule Vaccine uptake rates School
More information2015 Vaccine Preventable Disease Summary
2015 Vaccine Preventable Disease Summary 12251 James Street Holland, MI 49424 www.miottawa.org/healthdata Prepared April 2016 2015 Summary of Vaccine Preventable Diseases (VPD) Reported to Ottawa County
More informationFamily and Travel Vaccinations
Family and Travel Vaccinations We offer the full range of baby, child and family vaccinations. We are able to tailor schedules to your child s needs or international schedule. We have a suggested vaccination
More information3 rd dose. 3 rd or 4 th dose, see footnote 5. see footnote 13. for certain high-risk groups
Figure 1. Recommended immunization schedule for persons aged 0 through 18 years 2013. (FOR THOSE WHO FALL BEHIND OR START LATE, SEE THE CATCH-UP SCHEDULE [FIGURE 2]). These recommendations must be read
More informationRecommended Health Screenings
Recommended Health Screenings UnitedHealthcare appreciates the preventive care you deliver to our members. Please use the below health screening chart to schedule screenings based on the member s age and
More informationVACCINATION. DR.FATIMA ALKHALEDY M.B.Ch.B;F.I.C.M.S/C.M.
VACCINATION DR.FATIMA ALKHALEDY M.B.Ch.B;F.I.C.M.S/C.M. IMMUNIZATION Immunization is defined as the procedure by which the body is prepared to fight against a specific disease. It is used to induce the
More informationTHE KEATS GROUP PRACTICE REGISTRATION FORM PLEASE COMPLETE IN BLOCK CAPITALS PERSONAL BACKGROUND INFORMATION
Registration checked by: Date: 11 & Under THE KEATS GROUP PRACTICE REGISTRATION FORM PLEASE COMPLETE IN BLOCK CAPITALS PERSONAL BACKGROUND INFORMATION Male Female Has your child ever been treated at this
More informationUp-to-date immunization coverage rates among 2-year olds in Saskatchewan First Nations communities
Up-to-date immunization coverage rates among 2-year olds in Saskatchewan First Nations communities Presented by: Michelle Allard-Johnson BScN, RN Regional Immunization Coordinator First Nations Inuit Health
More informationRECOMMENDED IMMUNIZATIONS
Recommended Immunization Schedule for Persons Aged 0 Through 6 Years United States 2010 1 2 4 6 12 15 18 19 23 2 3 4 6 Vaccine Age Birth month months months months months months months months years years
More informationImmunization Coverage for 1, 2, & 7 Year Olds Immunization Coverage for 1, 2, & 7 Year Olds continued 1
Immunization Coverage for 1, 2, & 7 Year Olds Immunization Coverage for 1, 2, & 7 Year Olds continued 1 CHA REPORT 2004 Definition/Description: Childhood Immunization Rates This is the percentage of children
More informationSelected vaccine introduction status into routine immunization
Selected introduction status into routine infant immunization worldwide, 2003 This report summarizes the current status of national immunization schedules in 2003, as reported by Member States in the /UNICEF
More informationNew Jersey Department of Health Vaccine Preventable Disease Program Childhood and Adolescent Recommended Vaccines
New Jersey Department of Health Vaccine Preventable Disease Program Childhood and Adolescent Recommended Vaccines Antigens Vaccine Approved Age Daptacel Diphtheria, Tetanus, and acellular Pertussis (DTaP)
More informationUtah s Immunization Rule Individual Vaccine Requirements
Utah s Immunization Rule Individual Vaccine Requirements Which vaccines are required for school entry in Utah? Grades K-6: 5 doses DTaP (4 doses if the 4 th dose was given after the 4 th birthday) 4 doses
More information46825 (260) $UPONT
Be wise. Immunize. Keeping track of the shots your children receive can be confusing. This is an important responsibility that is shared by you and your immunization providers. This booklet contains the
More information2016 Vaccine Preventable Disease Summary
2016 Vaccine Preventable Disease Summary 12251 James Street Holland, MI 49424 www.miottawa.org/healthdata Prepared October 2017 2016 Summary of Vaccine Preventable Diseases (VPDs) Reported to Ottawa County
More information8: Applicability
Chapter 14 New Jersey State Sanitary Code Immunization of Pupils in Schools (New Jersey Administrative Code Citation 8:57-4.1 to 8:57-4.20) (Readopted with amendments September 20, 2003. Effective Date:
More informationSTUDIES HAVE REPORTED INcreased
ORIGINAL CONTRIBUTION Risk of Febrile Seizures and Epilepsy After Vaccination With Diphtheria, Tetanus, Acellular Pertussis, Inactivated Poliovirus, and Haemophilus Influenzae Type b Yuelian Sun, PhD Jakob
More informationVaccines for Children
Vaccines for Children 12 24 old Our goal is to offer your family the best care possible, which includes making sure your child is up to date on all vaccines. DTaP (Diptheria, Tetanus, Pertussis) Vaccine
More informationimmunisation in New Zealand
This appendix details the history of. Section A1.1 is a brief summary of when each vaccine was introduced to the National Immunisation Schedule (the Schedule). This summary includes vaccines which were
More informationDaycare, school entry and school program immunization report September Data for school years 2012/13 to 2014/15
Daycare, school entry and school program immunization report September 2015 Data for school years 2012/13 to 2014/15 Table of Contents Contents 1. Introduction... 0 2. Data Source... 1 3. Limitations...
More informationPakistan: WHO and UNICEF estimates of immunization coverage: 2017 revision
Pakistan: WHO and UNICEF estimates of immunization coverage: 2017 revision July 7, 2018; page 1 WHO and UNICEF estimates of national immunization coverage - next revision available July 15, 2019 data received
More informationANNUAL HEALTH SCREENINGS AND IMMUNIZATIONS GUIDE MEN WOMEN ALL ADULTS CHILDREN
AND IMMUNIZATIONS GUIDE MEN WOMEN ALL ADULTS CHILDREN MEN PROSTATE CANCER Testicular exam Age 18+ PSA test Ages 50-75, based on risk WOMEN BREAST CANCER Self breast exam Monthly Clinical breast exam Annually
More informationTable 1. Primary childhood immunisation schedule for children born between 01/07/2008 and 30/06/2015
ackground The national immunisation uptake statistics, based on available data, for Quarter 2 2015 are presented in this report. These immunisation uptake statistics relate to children at 12 (born between
More information2017 Vaccine Preventable Disease Summary
2017 Vaccine Preventable Disease Summary Prepared 12251 James Street Holland, MI 49424 www.miottawa.org/healthdata October 2018 2017 Summary of Vaccine Preventable Diseases in Ottawa County This is a detailed
More informationChanges for the School Year
February 8, 2018 Dear Immunization Provider: In accordance with South Carolina Code of Laws, Section 44-29-180, and South Carolina Regulation 61-8, the 2017-2018 "Required Standards of Immunization for
More informationImmunization Records. childrens.memorialhermann.org CARE /13
Immunization Records childrens.memorialhermann.org 713.222.CARE 4400209-4/13 Personal Health Record of The Woodlands Contact Information Date and time of birth Place of birth Pediatrician name, phone number
More information2016 Cross-Cutting Measure Set
1 0059 Diabetes: Hemoglobin A1c Poor Control: Percentage of patients 18-75 years of age with diabetes who had hemoglobin A1c > 9.0% during the 46 0097 Claims, Registry Medication Reconciliation Post Discharge:
More informationJournal Club 3/4/2011
Journal Club 3/4/2011 Maternal HIV Infection and Antibody Responses Against Vaccine-Preventable Diseases in Uninfected Infants JAMA. 2011 Feb 9;305(6):576-84. Jones et al Dept of Pediatrics, Imperial College,
More informationPneumococcal vaccination in UK: an update. Dr Richard Pebody Immunisation Department Health Protection Agency Centre for Infections
Pneumococcal vaccination in UK: an update Dr Richard Pebody Immunisation Department Health Protection Agency Centre for Infections Leading infectious causes of mortality, 2000 WHO estimates 3.5 Deaths
More informationI. In accordance with Virginia Code relative to enrollment of certain children in public schools:
Immunization Requirements I. In accordance with Virginia Code relative to enrollment of certain children in public schools: A. Children not properly immunized in accordance with the Virginia Department
More informationA. Children born in 1942 B. Children born in 1982 C. Children born in 2000 D. Children born in 2010
Who do you think received the most immunologic components in vaccines? Development of which vaccine slowed after the invention of antibiotics? A. Children born in 1942 B. Children born in 1982 C. Children
More informationRecommended Childhood Immunization Schedu...ates, January - December 2000, NP Central
Recommended Childhood Immunization Schedule United States, January - December 2000 Vaccines 1 are listed under routinely recommended ages. Solid-colored bars indicate range of recommended ages for immunization.
More informationWhite Plains YMCA 2016 Summer Camp Registration Form
White Plains YMCA 2016 Summer Camp Registration Form Camper Information Child s First Name: Child s Last Name: Date of Birth: Gender: Age: S L XL What grade will your child be entering in the Fall of 2016?:
More informationWhat DO the childhood immunization footnotes reveal? Questions and answers
What DO the childhood immunization footnotes reveal? Questions and answers Stanley E. Grogg, DO, FACOP, FAAP he Advisory Committee on Immunization Practices (ACIP) recommends the childhood vaccination
More informationQualChoice Preventive Care Benefits
QualChoice Preventive Care Benefits Individual and Group Plans with Effective Dates on or after January 1, 2014 (Non-Grandfathered) As your partner in health, we want to make sure you stay healthy and
More informationChanges for the School Year. The addition of NINTH grade to the requirement for four (4) doses of diphtheria, tetanus, and pertussis.
February 19, 2013 Dear Immunization Provider: In accordance with South Carolina Code of Laws, Section 44-29-180, and State Regulation 61-8, the 2013-2014 "Required Standards of Immunization for School
More informationStrep Test 87070, 87071, 87081, Pharyngitis (CWP)
Clinical Excellence Measures Use of these codes should be appropriate to the service(s) rendered and follow the billing guidelines. For HEDIS measures the codes are from the NCQA HEDIS specifications and
More informationSchools. Kindergarten
1 of 5 7/29/2014 4:14 PM Schools North Carolina law requires all children in the state to receive certain immunizations. Records are checked when children enter school or child care. Kindergarten Vaccination
More information2017/18 Immunisation programmes list of additional and enhanced services
2017/18 Immunisation programmes list of additional and enhanced services 2017/18 Vaccination and Immunisation list of additional and enhanced services Version number: 1 First published: April 2017 Prepared
More informationTable 1. Primary childhood immunisation schedule for children born between 01/07/2008 and 30/06/2015
ackground The national immunisation uptake statistics, based on available data, for Quarter 1 2015 are presented in this report. These immunisation uptake statistics relate to children at 12 (born between
More informationTable 1. Primary childhood immunisation schedule for children born between 01/07/2008 and 30/06/2015
ackground The national immunisation uptake statistics, based on available data, for Quarter 3 2015 are presented in this report. These immunisation uptake statistics relate to children at 12 (born between
More informationAdolescent vaccination strategies
Adolescent vaccination strategies Gregory Hussey Vaccines for Africa Initiative Institute of Infectious Diseases & Molecular Medicine University of Cape Town www.vacfa.uct.ac.za gregory.hussey@uct.ac.za
More informationSchool Year ALASKA CHILD CARE & SCHOOL IMMUNIZATION REQUIREMENT CHANGES
2009 2010 School Year ALASKA CHILD CARE & SCHOOL IMMUNIZATION REQUIREMENT CHANGES EFFECTIVE JULY 1, 2009 ALASKA IMMUNIZATION PROGRAM (907) 269-8000 OR 1-888-430-4321 Varicella: Immunization Documentation
More informationWelcome to the California Immunization Coalition Education Hour
Welcome to the California Immunization Coalition Education Hour 1 . New School Rules: What Providers and Parents Need to Know Webinar Objectives Understand the impact of Senate Bill 277 on medical practices
More informationWalter A. Orenstein, M.D. Professor of Medicine and Pediatrics Director, Emory Vaccine Policy and Development Associate Director, Emory Vaccine Center
Could Vaccines be a Possible Model For Pediatric Drug Development? June 13, 2006 Walter A. Orenstein, M.D. Professor of Medicine and Pediatrics Director, Emory Vaccine Policy and Development Associate
More information2018/19 Immunisation programmes list of additional and enhanced services
2018/19 Immunisation programmes list of additional and enhanced services 2018/19 Vaccination and Immunisation list of additional and enhanced services Version number: 1 First published: April 2018 Prepared
More informationSTANWOOD-CAMANO SCHOOL DISTRICT REQUEST FOR PART-TIME ATTENDANCE OR ANCILLARY SERVICES FROM PRIVATE SCHOOL PUPIL
STANWOOD-CAMANO SCHOOL DISTRICT REQUEST FOR PART-TIME ATTENDANCE OR ANCILLARY SERVICES FROM PRIVATE SCHOOL PUPIL 114 F2 Students Please complete ALL information: Name of Pupil Grade Address of Pupil City
More informationDaycare, school entry and school program immunization report. Data for school year 2016/17
Daycare, school entry and school program immunization report Data for school year 2016/17 Table of Contents 1. Introduction... 1 2. Data Source... 1 3. Limitations... 2 4. Daycare - Proof of Immunization...
More informationO N E R O O T, M A N Y R O U T E S Impact of User-Based System Design on Immunization Delivery
O N E R O O T, M A N Y R O U T E S Impact of User-Based System Design on Delivery CPHA 2016 Health Protection June 14, 2016 Authors Rosalie Tuchscherer, Saskatchewan Ministry of Health Jill Reedijk, British
More informationDaycare, school entry and school program immunization report. Data for school year 2015/16
Daycare, school entry and school program immunization report Data for school year 2015/16 Table of Contents Table of Content2 1. Introduction... 1 2. Data Source... 1 3. Limitations... 2 4. Daycare - Proof
More informationNOTE: The above recommendations must be read along with the footnotes of this schedule.
Figure 1. Recommended immunization schedule for persons aged 0 through 18 years 2013. (FOR THOSE WHO FALL BEHIND OR START LATE, SEE THE CATCH-UP SCHEDULE [FIGURE 2]). These recommendations must be read
More informationGardasil Network Development Project GARDASIL VACCINE QUESTIONNAIRE
Questionnaire ID Gardasil Network Development Project GARDASIL VACCINE QUESTIONNAIRE Answering this questionnaire is voluntary. Personal identifying information will not be shared with anyone outside of
More informationDecision to amend access criteria for some vaccines
3 July 2015 Decision to amend access criteria for some vaccines PHARMAC is pleased to announce the following changes to the funding access criteria for a number of vaccines. The changes in criteria follow
More informationGENERAL PRACTITIONER DATA PACK GUIDANCE
RESTRICTED For CQC internal use only This should NOT be shared outside CQC GENERAL PRACTITIONER DATA PACK GUIDANCE PRIMARY CARE DATA PACKS AND INSPECTION TEAM - November 2015 - Table of Contents Introduction...
More informationARKANSAS STATE BOARD OF HEALTH
ARKANSAS STATE BOARD OF HEALTH RULES AND REGULATIONS PERTAINING TO IMMUNIZATION REQUIREMENTS Promulgated Under the Authority of Ark. Code Ann. 20-7-109, 6-18-702, 6-60-501-504, and 20-78-206. By the Arkansas
More informationAPPENDIX EE VACCINE STATUS AND DATE
VACCINE STATUS AND DATE Vaccine Status, Date is a ten-character field which presents information about each of the vaccines required for children. For most cases, the first character tells the vaccine
More informationHistory and aims of immunisation. Dr Anna Clarke Department of Public Health Dr. Steevens Hospital Dublin 8
History and aims of immunisation Dr Anna Clarke Department of Public Health Dr. Steevens Hospital Dublin 8 Objectives To examine the history of immunisation To explain the aim of immunisation To develop
More informationExpanded Programme on Immunization (EPI)
Timor-Leste 217 Expanded Programme on Immunization (EPI) FACT SHEET Acronyms AD Auto disable MCV1 First dose measles containing vaccine AEFI Adverse events following immunization MCV2 Second dose measles
More informationPreventive health guidelines As of April 2012
Preventive health guidelines As of April 2012 What is your plan for better health? Make this year your best year for wellness. Your health plan may help pay for tests to find disease early and routine
More informationImmunization Documentation Upload instructions
Immunization Documentation Upload instructions 1. Log into Health-e-Messaging using your Kerberos ID and password. 2. Enter your student ID number. 3. From the left side of the screen choose either: Immunizations
More informationVaccine Innovation: Challenges and Opportunities to Protect Health. Julie Louise Gerberding, M.D., M.P.H President, Merck Vaccines
Vaccine Innovation: Challenges and Opportunities to Protect Health Julie Louise Gerberding, M.D., M.P.H President, Merck Vaccines Protecting Health with Vaccines HEALTH IMPROVEMENT Population Impact Guidelines
More informationFULL DAY Application Checklist
Batesville Primary School 760 State Road 46 West Batesville, IN 47006 812-934-4509 www.batesvilleinschools.com/bps Student s Name Last First Middle 2016-2017 FULL DAY Application Checklist The following
More informationBODY DEFENCES AGAINST DISEASE AND THE ROLE OF VACCINES
BODY DEFENCES AGAINST DISEASE AND THE ROLE OF VACCINES Topic 3 This topic links in with MICROBES (from unit 1) 1. What are the 3 types of microbes? 2. Which microbe do antibiotics destroy? 3. What microbe
More informationVaccination schedules in Denmark
Vaccination schedules in Denmark Tyra Grove Krause MD, PhD, Senior consultant Head of Dept. Of Infectious Disease Epidemiology and Prevention Statens Serum Institut e-mail: tgv@ssi.dk Agenda History of
More informationChild s Health 3 months Coding Legend Q No. SASCode Answer Selection SASVariableName
Child s Health 3 months Coding Legend Q No. SASCode Answer Selection SASVariableName [8888] Subject skipped the questionnaire [888] Not applicable [999] No response to this question [1]/[0] Inclusive selection
More informationFaith Academy Admission Form
Child s Child s Birth : / / Month day year First Middle Last Street Town State Zip Parent or Guardian 1 Parent or Guardian 2 Home Cell Work Email: Home Cell Work Email: Days of Attendance: Mondays from:
More information